[{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH01-01 Basic and applied nanotechnology and therapeutics,,"},{"Key":"Keywords","Value":"mRNA,Nanoparticle,Head and neck cancers,Metastasis,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>O. Taratula<\/b><sup>1<\/sup>, T. Korzun<sup>2<\/sup>, A. Jozic<sup>1<\/sup>, V. Grigoriev<sup>1<\/sup>, G. Sahay<sup>1<\/sup>, D. L. Marks<sup>3<\/sup>; <br\/><sup>1<\/sup>Oregon State University, Portland, OR, <sup>2<\/sup>Oregon Health & Science University, Portland, OR, <sup>3<\/sup>Endevica Bio, Inc., Northbrook, IL","CSlideId":"","ControlKey":"8e2c098f-7e82-4101-9451-15e1d9a1e515","ControlNumber":"10808","DisclosureBlock":"&nbsp;<b>O. Taratula, <\/b> None..<br><b>T. Korzun, <\/b> None..<br><b>A. Jozic, <\/b> None..<br><b>V. Grigoriev, <\/b> None.&nbsp;<br><b>G. Sahay, <\/b> <br><b>Enterx Bio<\/b> Stock Option. <br><b>Serina Tx<\/b> Stock Option. <br><b>Rare Air Inc<\/b> Stock Option. <br><b>D. L. Marks, <\/b> <br><b>Pfizer, Inc.<\/b> Other, Consultant. <br><b>Alkermes, Inc.<\/b> Other, Consultant. <br><b>Endevica Bio, Inc.<\/b> Employment, Consultant.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10363","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"1","PosterboardNumber":"1","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB019","PresenterBiography":null,"PresenterDisplayName":"Oleh Taratula, MS;PhD","PresenterKey":"2ab8d873-1f07-426a-a892-010b17dea154","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB019. Comprehensive therapeutic impact: Follistatin mRNA-loaded lipid nanoparticles halt lung metastases and prolong survival in murine head &#38; neck squamous cell carcinoma","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Comprehensive therapeutic impact: Follistatin mRNA-loaded lipid nanoparticles halt lung metastases and prolong survival in murine head &#38; neck squamous cell carcinoma","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH01-01 Basic and applied nanotechnology and therapeutics,,"},{"Key":"Keywords","Value":"Extracellular vesicles,Cancer,Drug resistance,Nanoparticle,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>A. Srivastava<\/b>, A. Paramananantham, R. Asfiya; <br\/>University of Missouri - Columbia, Columbia, MO","CSlideId":"","ControlKey":"28bd4ba7-7284-44de-aba8-b9c1faccad81","ControlNumber":"10701","DisclosureBlock":"&nbsp;<b>A. Srivastava, <\/b> None..<br><b>A. Paramananantham, <\/b> None..<br><b>R. Asfiya, <\/b> None.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10364","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"2","PosterboardNumber":"2","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB020","PresenterBiography":null,"PresenterDisplayName":"Akhil Srivastava, BS,MS,PhD","PresenterKey":"252276cd-6aa1-400d-9d1a-44bfc3af0910","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB020. Extracellular vesicle-mediated intrinsic induction of ferroptosis causes reversal of chemoresistance in lung cancer","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Extracellular vesicle-mediated intrinsic induction of ferroptosis causes reversal of chemoresistance in lung cancer","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH01-02 Chemoinformatics, in silico screening, and computational methods,,"},{"Key":"Keywords","Value":"Modeling,Bcl-2 protein family,Drug discovery,Autophagy,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"S. Calis<sup>1<\/sup>, B. Dogan<sup>2<\/sup>, A. Celebi<sup>3<\/sup>, O. Yapicier<sup>1<\/sup>, T. Kilic<sup>1<\/sup>, E. Tahir Turanli<sup>4<\/sup>, T. Avsar<sup>1<\/sup>, <b>S. Durdagi<\/b><sup>1<\/sup>; <br\/><sup>1<\/sup>BAU Bahçesehir University, Istanbul, Turkey, <sup>2<\/sup>Istanbul Technical University, Istanbul, Turkey, <sup>3<\/sup>Bahçesehir University, Istanbul, Turkey, <sup>4<\/sup>Acibadem University, Istanbul, Turkey","CSlideId":"","ControlKey":"f2278280-23c8-4ca2-a82d-46836f382811","ControlNumber":"10760","DisclosureBlock":"&nbsp;<b>S. Calis, <\/b> None..<br><b>B. Dogan, <\/b> None..<br><b>A. Celebi, <\/b> None..<br><b>O. Yapicier, <\/b> None..<br><b>T. Kilic, <\/b> None..<br><b>E. Tahir Turanli, <\/b> None..<br><b>T. Avsar, <\/b> None..<br><b>S. Durdagi, <\/b> None.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10365","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"3","PosterboardNumber":"3","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB021","PresenterBiography":null,"PresenterDisplayName":"Serdar Durdagi, BS;MS;PhD","PresenterKey":"845e93a0-0a5a-441c-bc40-f3f5a7cb3417","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB021. BAU-243: A novel BCL-2 inhibitor inducing autophagic cell death in glioblastoma, unveiled through multistep virtual screening, comprehensive in vitro and in vivo animal model evaluation","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"BAU-243: A novel BCL-2 inhibitor inducing autophagic cell death in glioblastoma, unveiled through multistep virtual screening, comprehensive in vitro and in vivo animal model evaluation","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH01-03 Drug delivery,,"},{"Key":"Keywords","Value":"Axl,Drug delivery,Targeted drug delivery,Xenografts,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"J. O. Humtsoe, A. Pothukuchi, <b>H. Kang<\/b>, P. Ha; <br\/>UCSF - University of California San Francisco, San Francisco, CA","CSlideId":"","ControlKey":"f1d5edfc-f13a-46bc-9a9c-281b44cd392e","ControlNumber":"10819","DisclosureBlock":"<b>&nbsp;J. O. Humtsoe, <\/b> <br><b>ADC therapeutics<\/b> Other, Received drugs for experiment.<br><b>A. Pothukuchi, <\/b> None.&nbsp;<br><b>H. Kang, <\/b> <br><b>NEJM Group; BMJ publishing group<\/b> Independent Contractor. <br><b>Eli-Lilly; NeoImmuneTech; PDS Biotechnology; Kura Oncology; Prelude Therapeutics<\/b> Other, Contracted research (institution). <br><b>Exelixis<\/b> Other, Scientific Advisory Board. <br><b>MitoImmune<\/b> Other, Data safety monitoring board. <br><b>PIN therapeutics<\/b> Other, Consultant. <br><b>P. Ha, <\/b> <br><b>Privo Technologies<\/b> Stock Option. <br><b>Atos Medical; Checkpoint Surgical; Wiley<\/b> Independent Contractor. <br><b>ADC Therapeutics<\/b> Other, Received drugs for experiments.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10366","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"4","PosterboardNumber":"4","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB022","PresenterBiography":"","PresenterDisplayName":"Hyunseok Kang, MD","PresenterKey":"da272d53-5ba6-4931-8dbc-3bbb9385b2ec","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB022. Preclinical anti-tumorigenic evaluation of AXL targeting antibody-drug-conjugate in an adenoid cystic carcinoma cell line xenograft model","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Preclinical anti-tumorigenic evaluation of AXL targeting antibody-drug-conjugate in an adenoid cystic carcinoma cell line xenograft model","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH01-03 Drug delivery,,"},{"Key":"Keywords","Value":"Drug delivery,Paclitaxel,Cancer therapy,Taxol,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>H. Huang, Sr.<\/b><sup>1<\/sup>, R. Huang<sup>2<\/sup>; <br\/><sup>1<\/sup>Hui Yu Huang (Individual), Guangzhou, China, <sup>2<\/sup>Meiji Biopharmaceutical Corporation Limited, Guangzhou, China","CSlideId":"","ControlKey":"de889310-19dc-4c6b-8083-bac95f94b5f6","ControlNumber":"10547","DisclosureBlock":"<b>&nbsp;H. Huang, <\/b> <br><b>Meiji Biopharmaceutical Incorporated Limited<\/b> Employment, CSO and founder of the company.<br><b>R. Huang, <\/b> None.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10367","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"5","PosterboardNumber":"5","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB023","PresenterBiography":null,"PresenterDisplayName":"Hui Yu Huang","PresenterKey":"b1d72340-450f-477d-b01e-cd7811b45b06","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB023. A novel oral Paclitaxel delivery strategy and softgel capsule product for improving cancer therapeutics","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"A novel oral Paclitaxel delivery strategy and softgel capsule product for improving cancer therapeutics","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH01-03 Drug delivery,,"},{"Key":"Keywords","Value":"Nanoparticle,Drug delivery,Carcinoma: adenocarcinoma,Cisplatin,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>M. Goldberg<\/b><sup>1<\/sup>, A. Manzi<sup>1<\/sup>, S. Cantin<sup>1<\/sup>, P. Conway<sup>1<\/sup>, J. Shikora<sup>1<\/sup>, A. McFarland<sup>1<\/sup>, M. Cayer<sup>1<\/sup>, L. Dunn<sup>1<\/sup>, C. Ball<sup>1<\/sup>, A. T. Pearson<sup>2<\/sup>, A. J. Rosenberg<sup>2<\/sup>, N. Agrawal<sup>2<\/sup>, E. Izumchenko<sup>2<\/sup>; <br\/><sup>1<\/sup>Privo Technologies, Peabody, MA, <sup>2<\/sup>University of Chicago, Chicago, IL","CSlideId":"","ControlKey":"2ed32c2a-2e01-4955-bcc5-bd95f1c43f5c","ControlNumber":"10749","DisclosureBlock":"&nbsp;<b>M. Goldberg, <\/b> None..<br><b>A. Manzi, <\/b> None..<br><b>S. Cantin, <\/b> None..<br><b>P. Conway, <\/b> None..<br><b>J. Shikora, <\/b> None..<br><b>A. McFarland, <\/b> None..<br><b>M. Cayer, <\/b> None..<br><b>L. Dunn, <\/b> None..<br><b>C. Ball, <\/b> None..<br><b>A. T. Pearson, <\/b> None..<br><b>A. J. Rosenberg, <\/b> None..<br><b>N. Agrawal, <\/b> None..<br><b>E. Izumchenko, <\/b> None.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10368","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"6","PosterboardNumber":"6","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB024","PresenterBiography":null,"PresenterDisplayName":"MANIJEH GOLDBERG, PhD, MBA, MS, MS, BS","PresenterKey":"c18dac18-3a03-41fd-abbe-12b4b8329e64","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB024. Permeation enhancer is necessary for the optimized PRV131 mediated cisplatin intratumoral delivery","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Permeation enhancer is necessary for the optimized PRV131 mediated cisplatin intratumoral delivery","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH01-06 Lead identification and optimization,,"},{"Key":"Keywords","Value":"Antibody-drug conjugate (ADC),NSCLC,c-Met,Preclinical,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>K. Lee<\/b>, S.-Y. Kim, H.-J. Hong, E. Park, J. Park, S.-H. Hong, D. Bae, N. Ha, S.-J. Yeon, I. Hwang, S. Kim, Y. Lee, J.-H. Lee; <br\/>CKD Research Institute, Gyeonggi-do, Korea, Republic of","CSlideId":"","ControlKey":"6b9cf3a2-8348-445d-bcb1-b47d14a03766","ControlNumber":"10346","DisclosureBlock":"<b>&nbsp;K. Lee, <\/b> <br><b>Chong Kun Dang<\/b> Employment. <br><b>S. Kim, <\/b> <br><b>Chong Kun Dang<\/b> Employment. <br><b>H. Hong, <\/b> <br><b>Chong Kun Dang<\/b> Employment. <br><b>E. Park, <\/b> <br><b>Chong Kun Dang<\/b> Employment. <br><b>J. Park, <\/b> <br><b>Chong Kun Dang<\/b> Employment. <br><b>S. Hong, <\/b> <br><b>Chong Kun Dang<\/b> Employment. <br><b>D. Bae, <\/b> <br><b>Chong Kun Dang<\/b> Employment. <br><b>N. Ha, <\/b> <br><b>Chong Kun Dang<\/b> Employment. <br><b>S. Yeon, <\/b> <br><b>Chong Kun Dang<\/b> Employment. <br><b>I. Hwang, <\/b> <br><b>Chong Kun Dang<\/b> Employment. <br><b>S. Kim, <\/b> <br><b>Chong Kun Dang<\/b> Employment. <br><b>Y. Lee, <\/b> <br><b>Chong Kun Dang<\/b> Employment. <br><b>J. Lee, <\/b> <br><b>Chong Kun Dang<\/b> Employment.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10369","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"7","PosterboardNumber":"7","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB025","PresenterBiography":null,"PresenterDisplayName":"Kwanwoo Lee","PresenterKey":"4f3f76d5-6ee8-4b56-a421-7ea5acf3c0ae","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB025. CKD-703, a novel antibody-drug conjugate targeting cMET with an enhanced therapeutic index in solid tumors","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"CKD-703, a novel antibody-drug conjugate targeting cMET with an enhanced therapeutic index in solid tumors","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH01-06 Lead identification and optimization,,"},{"Key":"Keywords","Value":"Cancer,Breast cancer,Leukemias,Drug discovery,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>Y. Wu<\/b>, K. Wu, J. Vadgama; <br\/>Charles Drew Univ. of Medicine & Science, Los Angles, CA","CSlideId":"","ControlKey":"d5dd83f1-24e1-4e93-a18a-a83ace24dec4","ControlNumber":"10841","DisclosureBlock":"&nbsp;<b>Y. Wu, <\/b> None..<br><b>K. Wu, <\/b> None..<br><b>J. Vadgama, <\/b> None.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10370","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"8","PosterboardNumber":"8","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB026","PresenterBiography":null,"PresenterDisplayName":"Yong Wu, PhD","PresenterKey":"b0a96b70-862f-4b1d-b522-fe025f4ce92e","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB026. Exploring MCT4 inhibitor Ful-23 and cytarabine synergy in acute myeloid leukemia therapeutics","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Exploring MCT4 inhibitor Ful-23 and cytarabine synergy in acute myeloid leukemia therapeutics","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH01-07 Natural products,,"},{"Key":"Keywords","Value":"Prostate cancer,High-throughput assay,Natural products,Androgen receptor,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>N. Tyagi<\/b><sup>1<\/sup>, S. Hosseiniporgham<sup>2<\/sup>, A. Tyagi<sup>1<\/sup>, B. Chandrasekaran<sup>1<\/sup>, K. Bonilla<sup>2<\/sup>, I. Kriger<sup>2<\/sup>, J. Saccchettini<sup>2<\/sup>, C. Damodaran<sup>1<\/sup>; <br\/><sup>1<\/sup>Department of Pharmaceutical Sciences, Texas A&M University, College Station, TX, <sup>2<\/sup>Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX","CSlideId":"","ControlKey":"5f16d419-5ded-4735-bb8e-5a0d6ee8527a","ControlNumber":"10826","DisclosureBlock":"&nbsp;<b>N. Tyagi, <\/b> None..<br><b>S. Hosseiniporgham, <\/b> None..<br><b>A. Tyagi, <\/b> None..<br><b>B. Chandrasekaran, <\/b> None..<br><b>K. Bonilla, <\/b> None..<br><b>I. Kriger, <\/b> None..<br><b>J. Saccchettini, <\/b> None..<br><b>C. Damodaran, <\/b> None.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10371","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"9","PosterboardNumber":"9","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB027","PresenterBiography":null,"PresenterDisplayName":"Neha Tyagi, BS;MS","PresenterKey":"8df00810-4158-4f85-8a91-21acdaa099bb","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB027. Identifying natural inhibitors of androgen receptor (AR) and its variants from NCI Natural Product Repository","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Identifying natural inhibitors of androgen receptor (AR) and its variants from NCI Natural Product Repository","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH01-09 Targeted protein degradation,,"},{"Key":"Keywords","Value":"Epigenetics,Multiple myeloma,Drug discovery,Gene regulation,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>Frederick  A.  Derheimer<\/b><sup><\/sup>, Ninvita Givarkes<sup><\/sup>, Natalie Miller<sup><\/sup>, Rita Grantner<sup><\/sup>, Casey Quinlan<sup><\/sup>, Sonja Brun<sup><\/sup>, Thomas Paul<sup><\/sup>, Sudhakar Chintharlapalli<sup><\/sup>, Astrid Ruefli-Brasse<sup><\/sup>, Stefan Steyn<sup><\/sup>, Derek Bartlett<sup><\/sup>, Matthew Hayward<sup><\/sup>, Matthew Brown<sup><\/sup>, Daniel Uccello<sup><\/sup>, Benjamin  J.  Burke<sup><\/sup>, Kris Borzilleri<sup><\/sup>, Adam Gilbert<sup><\/sup>, Michelle Hemkens<sup><\/sup><br><br\/>Pfizer Oncology, San Diego, CA","CSlideId":"","ControlKey":"699666b4-4ae9-45de-8010-bb65a4e43915","ControlNumber":"9741","DisclosureBlock":"<b>&nbsp;F. A. Derheimer, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>N. Givarkes, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>N. Miller, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>R. Grantner, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>C. Quinlan, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>S. Brun, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>T. Paul, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>S. Chintharlapalli, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>A. Ruefli-Brasse, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>S. Steyn, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>D. Bartlett, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>M. Hayward, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>M. Brown, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>D. Uccello, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>B. J. Burke, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>K. Borzilleri, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>A. Gilbert, <\/b> <br><b>Pfizer<\/b> Employment. <br><b>M. Hemkens, <\/b> <br><b>Pfizer<\/b> Employment.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10372","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"10","PosterboardNumber":"10","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB028","PresenterBiography":null,"PresenterDisplayName":"Frederick Derheimer, BS;PhD","PresenterKey":"dbbc0119-4e0b-4197-969f-4e98e4714f82","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB028. Discovery and characterization of selective heterobifunctional degraders of EP300 in hematopoietic malignancies","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discovery and characterization of selective heterobifunctional degraders of EP300 in hematopoietic malignancies","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH01-09 Targeted protein degradation,,"},{"Key":"Keywords","Value":"Transcription factor,Combination studies,Synthetic lethality,Proteasome-mediated degradation,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"R. Sawant<sup>1<\/sup>, M. Geitmann<sup>1<\/sup>, T. Gossas<sup>1<\/sup>, W. B. Emond<sup>1<\/sup>, U. Bremberg<sup>1<\/sup>, K. Koehler<sup>1<\/sup>, M. Ceribelli<sup>2<\/sup>, C. J. Thomas<sup>2<\/sup>, <b>P. Brandt<\/b><sup>1<\/sup>; <br\/><sup>1<\/sup>Beactica Therapeutics, Uppsala, Sweden, <sup>2<\/sup>National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD","CSlideId":"","ControlKey":"4eb13f83-e94f-4735-808d-727491e9b49b","ControlNumber":"10275","DisclosureBlock":"<b>&nbsp;R. Sawant, <\/b> <br><b>Beactica Therapeutics<\/b> Employment. <br><b>M. Geitmann, <\/b> <br><b>Beactica Therapeutics<\/b> Employment. <br><b>T. Gossas, <\/b> <br><b>Beactica Therapeutics<\/b> Employment. <br><b>W. B. Emond, <\/b> <br><b>Beactica Therapeutics<\/b> Employment, Previous employee at Beactica Therapeutics. <br><b>U. Bremberg, <\/b> <br><b>Beactica Therapeutics<\/b> Employment, Previous employee at Beactica Therapeutics. <br><b>K. Koehler, <\/b> <br><b>Beactica Therapeutics<\/b> Employment.<br><b>M. Ceribelli, <\/b> None..<br><b>C. J. Thomas, <\/b> None.&nbsp;<br><b>P. Brandt, <\/b> <br><b>Beactica Therapeutics<\/b> Employment.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10373","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"11","PosterboardNumber":"11","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB029","PresenterBiography":null,"PresenterDisplayName":"Peter Brandt","PresenterKey":"59df2f40-d7a6-467a-9266-b5044242928b","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB029. Degraders of TEAD transcription factors based on interface 3 binders","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Degraders of TEAD transcription factors based on interface 3 binders","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH01-09 Targeted protein degradation,,"},{"Key":"Keywords","Value":"Drug discovery,Molecular Glue,Protein homeostasis,Degrader,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>A. Jordan<\/b>, P. Addis, T. Allen, T. Ayra, S. Beck, R. Brant, R. Hjerpe, B. Gourdet, M. Jennings, R. Lawrence, S. Campbell-Maurer, P. Ng, L. Parkinson, E. Rejnowicz, G. Robles, E. Rosethorne, J. Shaw, D. Smith, D. Swift, D. Tait, S. Thomson, C. Tomlinson, A. Townley, S. Ward, C. Wilson; <br\/>Sygnature Discovery, Nottingham, United Kingdom","CSlideId":"","ControlKey":"b312c7fd-eb48-47f1-895c-8f50703f4905","ControlNumber":"10631","DisclosureBlock":"&nbsp;<b>A. Jordan, <\/b> None..<br><b>P. Addis, <\/b> None..<br><b>T. Allen, <\/b> None..<br><b>T. Ayra, <\/b> None..<br><b>S. Beck, <\/b> None..<br><b>R. Brant, <\/b> None..<br><b>R. Hjerpe, <\/b> None..<br><b>B. Gourdet, <\/b> None..<br><b>M. Jennings, <\/b> None..<br><b>R. Lawrence, <\/b> None..<br><b>S. Campbell-Maurer, <\/b> None..<br><b>P. Ng, <\/b> None..<br><b>L. Parkinson, <\/b> None..<br><b>E. Rejnowicz, <\/b> None..<br><b>G. Robles, <\/b> None..<br><b>E. Rosethorne, <\/b> None..<br><b>J. Shaw, <\/b> None..<br><b>D. Smith, <\/b> None..<br><b>D. Swift, <\/b> None..<br><b>D. Tait, <\/b> None..<br><b>S. Thomson, <\/b> None..<br><b>C. Tomlinson, <\/b> None..<br><b>A. Townley, <\/b> None..<br><b>S. Ward, <\/b> None..<br><b>C. Wilson, <\/b> None.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10374","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"12","PosterboardNumber":"12","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB030","PresenterBiography":null,"PresenterDisplayName":"Allan Jordan, PhD","PresenterKey":"4183405c-7014-4193-97f4-1bb485754418","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB030. Building a platform of validated high throughput screening approaches for molecular glue degrader identification","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Building a platform of validated high throughput screening approaches for molecular glue degrader identification","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH01-10 Other,,"},{"Key":"Keywords","Value":"KRAS,GTPase activating protein,SOS1,MAPK,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"Q. Xie, D. Li, S. Jiang, J. Zhu, S. Yu, M. Yang, Y. Cai, L. Liu, B. Yu, W. Tu, <b>Y. Zhang<\/b>, L. Li; <br\/>Haihe Biopharma Co., Ltd., Shanghai, China","CSlideId":"","ControlKey":"3feecbd9-fe18-49a1-8401-f7ee9ec14b8b","ControlNumber":"9815","DisclosureBlock":"<b>&nbsp;Q. Xie, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>D. Li, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>S. Jiang, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>J. Zhu, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>S. Yu, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>M. Yang, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>Y. Cai, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>L. Liu, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>B. Yu, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>W. Tu, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>Y. Zhang, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>L. Li, <\/b> <br><b>Haihe Biopharm<\/b> Employment.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10375","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"13","PosterboardNumber":"13","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB031","PresenterBiography":null,"PresenterDisplayName":"Yixiang Zhang, PhD","PresenterKey":"84c132ce-8ffe-42eb-816e-38de9f57809f","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB031. Discovery and Characterization of HH100937, a potent and selective SOS1 inhibitor demonstrates synergistic efficacy in combination with KRAS\/MAPK therapies","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discovery and Characterization of HH100937, a potent and selective SOS1 inhibitor demonstrates synergistic efficacy in combination with KRAS\/MAPK therapies","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH01-10 Other,,"},{"Key":"Keywords","Value":"PARP,PARP inhibitors,DNA repair,Breast cancer,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"Y. Hou, S. Gao, S. Jiang, J. Li, C. Zhang, Y. Xu, S. Yu, L. Liu, B. Yu, W. Tu, <b>Y. Zhang<\/b>, L. Li; <br\/>Haihe Biopharma Co., Ltd., Shanghai, China","CSlideId":"","ControlKey":"d63dde36-7f38-4d91-b651-6b4276a0ca37","ControlNumber":"9813","DisclosureBlock":"<b>&nbsp;Y. Hou, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>S. Gao, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>S. Jiang, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>J. Li, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>C. Zhang, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>Y. Xu, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>S. Yu, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>L. Liu, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>B. Yu, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>W. Tu, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>Y. Zhang, <\/b> <br><b>Haihe Biopharm<\/b> Employment. <br><b>L. Li, <\/b> <br><b>Haihe Biopharm<\/b> Employment.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10376","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"14","PosterboardNumber":"14","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB032","PresenterBiography":null,"PresenterDisplayName":"Yixiang Zhang, PhD","PresenterKey":"84c132ce-8ffe-42eb-816e-38de9f57809f","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB032. HH102007 is a highly selective and potent PARP1 inhibitor and trapper","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"HH102007 is a highly selective and potent PARP1 inhibitor and trapper","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH03-02 Small molecule, protein, and nucleic acid interactions,,"},{"Key":"Keywords","Value":"YAP\/TAZ,Tumor targeting,Gastrointestinal cancers: stomach,Therapeutics,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>R. Kumar<\/b><sup>1<\/sup>, J. Toh<sup>1<\/sup>, J. Thian<sup>1<\/sup>, N. F. H. Mohideen<sup>1<\/sup>, J. Sun<sup>1<\/sup>, S. Chakraborty<sup>2<\/sup>, J. Gunaratne<sup>1<\/sup>, W. Hong<sup>1<\/sup>; <br\/><sup>1<\/sup>Institute of Molecular and Cell Biology, Singapore, Singapore, <sup>2<\/sup>Roswell Park Comprehensive Cancer Center, Buffalo, NY","CSlideId":"","ControlKey":"9059ad4c-9b65-4877-8f6d-c8a957cac10d","ControlNumber":"10675","DisclosureBlock":"&nbsp;<b>R. Kumar, <\/b> None..<br><b>J. Toh, <\/b> None..<br><b>J. Thian, <\/b> None..<br><b>N. F. H. Mohideen, <\/b> None..<br><b>J. Sun, <\/b> None..<br><b>S. Chakraborty, <\/b> None..<br><b>J. Gunaratne, <\/b> None..<br><b>W. Hong, <\/b> None.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10377","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"15","PosterboardNumber":"15","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB033","PresenterBiography":null,"PresenterDisplayName":"Ramesh Kumar, PhD","PresenterKey":"b566dfa8-a307-4e4e-a9aa-f5c896d68560","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB033. Identification of small molecule Pan-TEAD inhibitors disrupting YAP-TEAD protein-protein interaction and targeting gastric cancer cells","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Identification of small molecule Pan-TEAD inhibitors disrupting YAP-TEAD protein-protein interaction and targeting gastric cancer cells","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH03-02 Small molecule, protein, and nucleic acid interactions,,"},{"Key":"Keywords","Value":"Antitumor effect,Peptides,Breast cancer,Xenografts,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>A. Tripathi<\/b>, J. K. Vishwanatha; <br\/>University of North Texas Health Science Ctr., Fort Worth, TX","CSlideId":"","ControlKey":"0abbcfdf-d02e-46c9-8d73-c3ee16cdc720","ControlNumber":"9551","DisclosureBlock":"&nbsp;<b>A. Tripathi, <\/b> None..<br><b>J. K. Vishwanatha, <\/b> None.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10378","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"16","PosterboardNumber":"16","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB034","PresenterBiography":null,"PresenterDisplayName":"AMIT Kumar Tripathi, PhD","PresenterKey":"c95bde84-547f-46cb-bf96-aa33ab5c8aff","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB034. First-in-class compounds targeting the MIEN1 signaling pathway: A breakthrough approach for breast and prostate cancer therapy","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"First-in-class compounds targeting the MIEN1 signaling pathway: A breakthrough approach for breast and prostate cancer therapy","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH03-03 Target identification, small molecule probes, and libraries,,"},{"Key":"Keywords","Value":"Proteomics,Chemistry,RNA,Stress response,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>K.-L. Hsu<\/b><sup>1<\/sup>, A. M. Ciancone<sup>2<\/sup>, K. W. Seo<sup>3<\/sup>, M. Chen<sup>2<\/sup>, A. L. Borne<sup>2<\/sup>, A. H. Libby<sup>2<\/sup>, D. L. Bai<sup>2<\/sup>, R. E. Kleiner<sup>3<\/sup>; <br\/><sup>1<\/sup>The University of Texas At Austin, Austin, TX, <sup>2<\/sup>The University of Virginia, Charlottesville, VA, <sup>3<\/sup>Princeton University, Princeton, NJ","CSlideId":"","ControlKey":"1ba23e6c-c0c2-4ebf-a3ae-875ef8a724b7","ControlNumber":"10407","DisclosureBlock":"<b>&nbsp;K. Hsu, <\/b> <br><b>Hyku Biosciences<\/b> Stock, Stock Option, Grant\/Contract, Patent.<br><b>A. M. Ciancone, <\/b> None..<br><b>K. W. Seo, <\/b> None..<br><b>M. Chen, <\/b> None..<br><b>A. L. Borne, <\/b> None..<br><b>A. H. Libby, <\/b> None..<br><b>D. L. Bai, <\/b> None..<br><b>R. E. Kleiner, <\/b> None.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10379","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"17","PosterboardNumber":"17","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB035","PresenterBiography":null,"PresenterDisplayName":"Ku-Lung Hsu, PhD","PresenterKey":"00929e12-7a7a-4ba6-b172-94b8953da6ab","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB035. Targeting cytoplasmic condensates in the stress response of cancer cells","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Targeting cytoplasmic condensates in the stress response of cancer cells","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH03-03 Target identification, small molecule probes, and libraries,,"},{"Key":"Keywords","Value":"Metastasis,DNA,Vimentin,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>C. Sissi<\/b><sup>1<\/sup>, M. Cozzaglio<sup>1<\/sup>, R. Rigo<sup>1<\/sup>, N. Dal Ponte<sup>1<\/sup>, M. Rotondo<sup>2<\/sup>, S. Ceschi<sup>1<\/sup>, B. BIondi<sup>3<\/sup>, B. Spolaore<sup>1<\/sup>; <br\/><sup>1<\/sup>University of Padua, Padova, Italy, <sup>2<\/sup>University of Naples Federico II, Naples, Italy, <sup>3<\/sup>CNR, Padova, Italy","CSlideId":"","ControlKey":"c252b97c-1149-4ace-a6b7-977027e870c1","ControlNumber":"10549","DisclosureBlock":"&nbsp;<b>C. Sissi, <\/b> None..<br><b>M. Cozzaglio, <\/b> None..<br><b>R. Rigo, <\/b> None..<br><b>N. Dal Ponte, <\/b> None..<br><b>M. Rotondo, <\/b> None..<br><b>S. Ceschi, <\/b> None..<br><b>B. BIondi, <\/b> None..<br><b>B. Spolaore, <\/b> None.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10380","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"18","PosterboardNumber":"18","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB036","PresenterBiography":null,"PresenterDisplayName":"Claudia Sissi, PhD","PresenterKey":"e4863988-0774-40d1-8e5f-7b7ded5b7e4d","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB036. Back and forth from structure to functional target: The interplay between Vimentin and non-canonical nucleic acid arrangements","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Back and forth from structure to functional target: The interplay between Vimentin and non-canonical nucleic acid arrangements","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CH03-05 Other,,"},{"Key":"Keywords","Value":"STAT3,Transcription factor,Targeted therapy,Proteasome-mediated degradation,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>K. Sharma<\/b>, X. Fei, Y. Shi, C. Browne, D. Walther, C. Daigle, A. Ramanathan, R. Miller, K. Yuan, K. Mahasenan, S. Zhu, X. Huang, B. Yang; <br\/>Kymera Therapeutics, Watertown, MA","CSlideId":"","ControlKey":"08c205d8-51b5-4e0a-8196-f3e2b42ff0a7","ControlNumber":"10704","DisclosureBlock":"<b>&nbsp;K. Sharma, <\/b> <br><b>Kymera Therapeutics<\/b> Employment, Other, Equity Owner. <br><b>X. Fei, <\/b> <br><b>Kymera Therapeutics<\/b> Employment, Other, Equity Owner. <br><b>Y. Shi, <\/b> <br><b>Kymera Therapeutics<\/b> Employment, Other, Equity Owner. <br><b>C. Browne, <\/b> <br><b>Kymera Therapeutics<\/b> Employment, Other, Equity Owner. <br><b>D. Walther, <\/b> <br><b>Kymera Therapeutics<\/b> Employment, Other, Equity Owner. <br><b>C. Daigle, <\/b> <br><b>Kymera Therapeutics<\/b> Employment, Other, Equity Owner. <br><b>A. Ramanathan, <\/b> <br><b>Kymera Therapeutics<\/b> Employment, Other, Equity Owner. <br><b>R. Miller, <\/b> <br><b>Kymera Therapeutics<\/b> Employment, Other, Equity Owner. <br><b>K. Yuan, <\/b> <br><b>Kymera Therapeutics<\/b> Employment, Other, Equity Owner. <br><b>K. Mahasenan, <\/b> <br><b>Kymera Therapeutics<\/b> Employment, Other, Equity Owner. <br><b>S. Zhu, <\/b> <br><b>Kymera Therapeutics<\/b> Employment, Other, Equity Owner. <br><b>X. Huang, <\/b> <br><b>Kymera Therapeutics<\/b> Employment, Other, Equity Owner. <br><b>B. Yang, <\/b> <br><b>Kymera Therapeutics<\/b> Employment, Other, Equity Owner.","End":"4\/7\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10381","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"19","PosterboardNumber":"19","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB037","PresenterBiography":null,"PresenterDisplayName":"Kirti Sharma","PresenterKey":"0c4252e6-dbb8-47bd-81d5-54f564680eb4","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB037. E3 pairing and structural mechanisms underlying anti-tumor activity of clinical STAT3 degrader KT-333","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  1:30PM","SessionId":"593","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Chemistry","ShowChatLink":"false","Start":"4\/7\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"E3 pairing and structural mechanisms underlying anti-tumor activity of clinical STAT3 degrader KT-333","Topics":null,"cSlideId":""}]